Inventor
Shrenik K. Shah
Inventor
Metuchen, NJ, US
Overview
Patents· 52 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds47%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes11%
C07CAcyclic or carbocyclic compounds7%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
C07HSugars1%
C07KPeptides1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,934,580Molecular quality assurance methods for use in sequencing202110,456,418Preparation of pharmaceutical dosage forms containing iron (III) salts20199,718,777'Process for the preparation of high purity miglustat'20179,108,920'Diazeniumdiolate heterocyclic derivatives'20158,754,099'Oxadiazole beta carboline derivatives as antidiabetic compounds'20148,361,994'Primary amine diazeniumdiolate heterocyclic derivatives'20137,816,534'Substituted amides'20107,667,053'Bicyclic amides'20107,572,785'Substituted imidazoles as cannabinoid receptor modulators'20097,550,489'Substituted pyridyoxy amides'20097,423,067'Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists'20087,390,835'Aralkyl amines as cannabinoid receptor modulators'20087,091,216'Substituted furo[2,3-b]pyridine derivatives'20067,057,051'Substituted imidazoles as cannabinoid receptor modulators'20066,972,295'Substituted amides'20056,943,180'Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors'20056,855,708'N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors'20056,638,930'Morpholine and thiomorpholine tachykinin receptor antagonists'20036,593,346'N-cyclopentyl modulators of chemokine receptor activity'20036,559,174'N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors'20036,482,840'Substituted cyclic amidine derivatives as inhibitors of cell adhesion'20026,372,733'Hexahydro-5-imino-1,4-1,4-thiazepine derivatives as inhibitors of nitric oxide synthases'20026,358,979'N-cyclopentyl modulators of chemokine receptor activity'20026,248,755'Pyrrolidine modulators of chemokine receptor activity'20016,235,735'Morpholine and thiomorpholine tachykinin receptor antagonists'20016,048,859'Morpholine and thiomorpholine tachykinin receptor antagonists'20006,043,358'Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases'20006,013,652'Spiro-substituted azacycles as neurokinin antagonists'20005,972,975'Substituted 2-aminopyridines as inhibitors of nitric oxide synthase'19995,952,321'Substituted azetidinones as anti-inflammatory and antidegenerative agents'19995,922,706'Morpholine and thiomorpholine tachykinin receptor antagonists'19995,908,842'Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase'19995,872,116'Morpholine and thiomorpholine tachykinin receptor antagonists'19995,869,496'Spiro-substituted azacycles as tachykinin receptor antagonists'19995,869,489'Trypthophan ureas as neurokinnin antagonists'19995,747,485'Substituted azetidiones as anti-inflammatory and antidegenerative agents'19985,719,147'Morpholine and thiomorpholine tachykinin receptor antagonists'19985,637,699'Process for preparing morpholine tachykinin receptor antagonists'19975,629,322'Cyclic amidine analogs as inhibitors of nitric oxide synthase'19975,607,936'Substituted aryl piperazines as neurokinin antagonists'19975,591,737'Substituted azetidinones as anti-inflammatory and antidegenerative agents'19975,434,158'Spiro-substituted azacycles as neurokinin-3 antagonists'19955,420,010'Assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones'19955,364,848'Substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents'19945,348,953'Substituted azetidinones as anti-inflammatory and antidegenerative agents'19945,276,139'Haptens useful in evaluating inhibition of PNN elastase by N-substituted azetidinones'19945,229,381'Substituted azetidinones as anti-inflammatory and antidegenerative agents'19935,132,301'Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents'19924,845,088'Tetrazolyl derivatives of beta-lactams useful as elastase inhibitors'19894,699,904'Tetrazolyl derivatives of .beta.-lactams useful as elastase inhibitors'19874,623,645'Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents'19864,547,371'Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents'1985Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1985–2010Patents assigned to MERCK & CO INC (45)· patent assignee history
1985–1986Based in Clark, NJ, US· patent location history
1987–2019Based in Metuchen, NJ, US· patent location history
1999Based in Rahway, NJ, US· patent location history
2010–2015Patents assigned to MERCK SHARP & DOHME (4)· patent assignee history
2013–2019Patents assigned to SHAH SHRENIK K (5)· patent assignee history
2013–2015Patents assigned to ALI AMJAD (2)· patent assignee history
2013–2015Patents assigned to GUO ZHIQIANG (2)· patent assignee history
2021Based in Vancouver, CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK & CO INC | 45 | 1985–2010 |
| SHAH SHRENIK Kself | 5 | 2013–2019 |
| MERCK SHARP & DOHME | 4 | 2010–2015 |
| ALI AMJAD | 2 | 2013–2015 |
| GUO ZHIQIANG | 2 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Metuchen, New Jersey, US | 47 | 1987–2019 |
| Rahway, New Jersey, US | 2 | 1999 |
| Clark, New Jersey, US | 2 | 1985–1986 |
| Vancouver, CA | 1 | 2021 |